chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a 16 year old female, who, on an unspecified date "several weeks ago", was vaccinated intramuscularly with a 0.5mL first dose of Gardasil.  Concomitant therapy included "another vaccine" (therapy unspecified).  Subsequently the patient experienced nausea and dizziness.  The patient did not seek medical attention.  The patient recovered the same day on an unspecified date.  No product quality complaint was involved.  Additional information has been requested.
Patient who received 2 doses of covid-19 vaccine (Pfizer) is now Covid positive with chest x-ray positive for covid pneumonia. Patient reports symptoms has started 5 days prior to admission, 2nd dose; Patient who received 2 doses of covid-19 vaccine (Pfizer) is now Covid positive with chest x-ray positive for covid pneumonia. Patient reports symptoms has started 5 days prior to admission, 2nd dose; This is a spontaneous report from a non-contactable Other HCP. An 87-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on Feb2021 at 100 ug/ml (30mcg/0.3mL), single for Covid-19 immunisation. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at age of 87-year-old for Covid-19 immunisation. The patient who received 2 doses of cCvid-19 vaccine (Pfizer) was now Covid positive with chest X-ray positive for Covid pneumonia in Feb2021. Patient reports symptoms has started 5 days prior to admission, 2nd dose was administered 10 days prior to admission. No COVID tested post vaccination. Decadron and remdesivir were received for the event. Outcome of the events was unknown.  No follow up attempts are possible; Information about lot/batch number cannot be obtained.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events. However the short duration of 5 days since the vaccine second dose is given it is unlikely patient would have fully developed immunity.
Patient has not experienced any adverse events, however she did bring to our attention on 9/17/21 that she has received her second dose on day 14, instead of day 21.
This medically confirmed report (initial receipt 19-Sep-2012) concerns a male patient in his 80s with a medical history of chickenpox aged 10. Concomitant medication included prostaglandin. On 13-Sep-2012, the patient received an unspecified flu vaccine (manufacturer and batch no. nor specified). On 15-Sep-2012 the patient developed a rash on his mid stomach and back and pain. Treatment included unspecified antiviral medication, prednisone and topical medication. The outcome for the event was recovering.
Patient states on 02/22/21 she got a big red rash with bumps on her right arm and when she lifts her right arm to shoulder height it hurts.  She will be seeing the physician.
Patient has a fever of 104 and she has chest pain.  A complication of the COVID-19 Vaccines in Children is Myocarditis.  Patient will need to be further evaluated for possible Myocarditis.  Parent has been told to take patient to the Emergency Room for further evaluation.
Patient was 12.5 years old at the time of vaccination. Was administered the pediatric formulation/dose, despite not being age-eligible for this vaccine.  Per CDC guidance,  patient received 2nd dose 21 days later, using the adult formulation and dose.
Pt recvd 2nd dose of Engerix-B 15JUL92 15mins later exp dizziness then exp difficulty breathing; DPH;
Pfizer-BioNTech COVID-19 At about 7:30 pm, approx 7-8 hour post injection, I had some jaw tightness and began to see flashing lights out of the left side of my left eye. They were still present when I awoke at 5:30-6:00 am on Tuesday.
I got the shot on 1/4/2021 and on 1/12/2021 I woke up with my right arm hurting .  The area all around the injection site wastender, swollen, somewhat red and hot. vAs of this date 1/15/2021, it remains the same.
Approximately 24 hours after receiving the vaccine, left arm punctured area became red, hot, tight and sore. The 2nd day after vaccination the area was somewhat itchy for that day. Area is increasing in size daily. Currently 5 & 3/4 inches in height by 7 & 1/2 inches in width. 18 hours after vaccination began feeling general fatigue, chills and body aches which continue. Benadryl is not really helping. Tylenol & Ibuprofen help for the body aches. When she gets bee stings it's almost the same reaction. When she takes Penicillin she developed hives and rashes. She has never been prescribed an epi-pen. Denies any breathing or vision changes. No recent changes in medication. Advised consult w/ her M.D. A.S.A.P.
Excessing/ extremely heavy  Menstrual bleeding  for more than 3 week . Hormones were prescribed, was admitted to the hospital for a blood transfusion.  Seems to be resolved but not sure if it may reoccure.
24hrs after vaccine administration, patient came back to office with moderate dehydration and emesis. Patient was sent to emergency department for IV fluids where she was diagnosed with intussusception.
Patient received vaccine on 10/30 - she had fever and chills on 30 th  patient has a seizure on 31st
This spontaneous report was received from a certified medical assistant referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown date, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 lot number M036728 and expiration date of 20-MAY-2018 for prophylaxis (dose and route of administration were not provided). The vaccine was exposed to a temperature excursion of 47.1°F with a time frame of 30 minutes. There was no previous temperature excursion. A "data logger" was involved. No adverse effects were reported. This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-1710USA006357: US-009507513-1710USA006358: US-009507513-1710USA006359: US-009507513-1710USA006360: US-009507513-1710USA006361: US-009507513-1710USA006362: US-009507513-1710USA006373: US-009507513-1710USA006364: US-009507513-1710USA006365: US-009507513-1710USA006366: US-009507513-1710USA006367: US-009507513-1710USA006368: US-009507513-1710USA006369: US-009507513-1710USA006370: US-009507513-1710USA006371: US-009507513-1710USA006372: US-009507513-1710USA006356: US-009507513-1710USA006355: US-009507513-1709USA011980:
Shot was given up high on my right shoulder. Soreness from shot continued. 3/14/00: I discussed pain in shoulder with Dr.  while in the office for other purpose-he thought immunization might have hit the bursas in my right shoulder. Tried 3 ibuprophin twice daily in Sept/Oct 2001.  10/29/01: Dr. referred me to physical therapy for right should pain.  11/16/01-12/27/01: went to physical therapy.  The therapist suggested that there might be other problems beyond what therapy could do for me.  1/21/02: x-ray of right shoulder. 2/4/02: Dr.  diagnosed osteoartritis in my right shoulder and gave me my 1st cortisone shot.  11/11/02: Returned to Dr. and received a 2nd cortosone shot.  Shoulder is still painful from the arthitis in the same location as I had received the flu shot. The follow up states the date of the flu immunization is incorrect in the letter and on the authorizations for release of info. It should be 10/8/99, not 10/8/02. I changed the date. I didn't provide the following info when I filed the original report. I was taking a prescription medication for cyclobenzaprine 10mg after seeing physician's assistant. This was also for the right shoulder (muscle strain). I received physical therapy from 11/16/01-12/27/01. I didn't give you the name of the provider in the original report. I'm mailing the authorizations for release of info today. Degenerate AC joint change.
Swelling at site of injection. Started within 1 hour of injection (noted on ride home). Swelling increased, and pain increased, a day later. Arm still swollen, less so, two days after injection.  Pain reduced but still present two days after injection. Advised ice pack yesterday. Swelling seems to have gone down by 56 hours after injection, only slight. (but has lasted past 48 hours.
Patient had first COVID19 vaccine administered at pharmacy. She has anxiety regarding needles and vaccines. I administed the vaccine in the counseling room and requested she remain in the room until she felt ok. Patient said she felt fine after about a minute, and she moved to the pharmacy waiting area. The patient called out that something was wrong from the waiting area after about 5 minutes. Pharmacist and technicians went over and patient reported loss of vision and hearing. She said she could not see anything and that her hearing wasn't right. The nurse practitioner on duty provided a cool compress for the head and neck, as well as juice. Patient remained in the waiting area for about 10 minutes and then was moved to the little clinic room to lay down. She remained in the clinic room for another 10 minutes until she felt better. Patient did not lose consciousness, was able to walk out of clinic to her car.
This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored Program. A female patient of an unspecified age received PREVNAR 13, via an unspecified route of administration on an unspecified date in 2015 or 2016 at single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she got her regular pneumonia vaccine then had pneumococcal 13-val conj vac (dipht crm197 protein). In 2017, patient had her lower lobe of the lung was removed from lung cancer on an unspecified date. The outcome of event was unknown.
10/19 began having headache during 3 hour drive and it became more intense the longer I went. When I arrived home I felt feverish and it was above 100. Tested on at home COVID-19 test and it was positive. The night was long and difficult. Fever increased and was not controlled well by acetaminophen. Also had, cough, congestion, fatigue, and body aches. Called my transplant center and was instructed to rest and come in the following day for monoclonal antibodies. Symptoms began resolving 2-3 days after infusion. The worst symptoms lasted 5-6 days and symptoms resolved around day 10-11.
Case number PHEH20214US021310 is an initial spontaneous report received from a nurse on 22 Oct 2014. This case refers to a 16 year old male patient. Past medical history and concomitant medication were not reported. He was vaccinated with an expired dose of MENVEO (batch number: not reported), intramuscularly on 20 Oct 2014. No adverse event was reported following this administration error.
Nausea; Vomiting for full 3 days so far; Mild headache; Pain in left side of neck; Stiff joints; Feverish; This is a spontaneous report from a contactable consumer or other non hcp (patient).   A 50-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection,), via an unspecified route of administration, administered in left arm on 06Feb2021 08:30 AM (age at vaccination was 50 years) (Batch/Lot number was not reported) as dose 1, single for covid-19 immunization. The patient medical history included seasonal allergy, asthma, food allergy with walnut, anxiety, bipolar disorder. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not test COVID-19 positive prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 06Feb2021 08:45 the patient experienced moderate nausea and vomiting for full 3 days so far, (trying to find out how many days this will go on) mild headache, pain in left side of neck, stiff joints, feverish. No treatment was received for the event. The outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
Patient presented to Hospital 5 days after second Pfizer dose with myocardial infarction involving the Left Anterior Descending artery. He had no significant risk factors for coronary artery disease.  He reports feeling very fatigue and dyspneic after first dose, and started to have chest pain after second dose.
This case was reported by a pharmacist via call center representative and described the occurrence of flu symptoms in a 38-year-old female patient who received FLUARIAX QUADRIVALENT (batch number 23J79, expiry date June 2016). Previously administered products included unspecified vaccine (no serious reactions to previous vaccines). Concomitant products included cyclobenzaprine and Z pack. On the 18th August 2015, the patient received the 1st dose of FLUARIX QUADRIVALENT .5 ml. On 19th August 2015, 1 days after receiving FLUARIX QUADRIVALENT, the patient experienced flu symptoms. On an unknown date, the outcome of the flu symptoms was not recovered/not resolved. The reporter considered the flu symptoms to be probably related to FLUARIX QUADRIVALENT. Additional details were provided as follows: On 18th August 2015, at 20.30 pm, the patient received the 1st dose of FLUARIX QUADRIVALENT. The reported batch number 23579, dose not exist but according to the sales data the correct batch number should be 23J79. This case was not previously reported to anyone.
got the first vaccine and then tested positive for the virus; got the first vaccine and then tested positive for the virus/fairly sick; This is a spontaneous report from Pfizer-sponsored Program IBCC (Inbound Call Center for HCPs). A contactable physician reported similar events for two patients. This is the first of two reports.  A patient of unspecified age and gender received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number and expiration date: not known), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter is a cardiologist. He is inquiring about the COVID-19 vaccine. He had several patients (pending clarification) who got the first vaccine and then tested positive for the virus. He is asking when can they get the second dose after testing positive. He had two patients that are fairly sick now. He has had patients who have monochromal antibodies (pending clarification). He is asking when they can get the vaccine after that treatment. The outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation between vaccination and onset of events.,Linked Report(s) : US-PFIZER INC-2021022171 same reporter, similar suspect drug and event; different patient
The patient received a third dose of the Moderna vaccine. The staff found out this had happened on Monday April 5th, 2021, the vaccine was administered on April 2nd.
Soreness; Body aches; Fever of 100.7; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), PAIN (Body aches), PYREXIA (Fever of 100.7) and CHILLS (Chills) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism since 01-Jul-1977, Sleep apnea (Recent change in status of chronic condition took place. On 08-Apr-2021 a sleep study found that the patient have Central apnea.) since 13-May-2009 and Drug hypersensitivity (Allergy to Hydrocodone). Concomitant products included ATORVASTATIN from 2000 to an unknown date for High cholesterol, LEVOTHYROXINE SODIUM (SYNTHROID) from 1977 to an unknown date for Hypothyroidism, VITAMIN D [VITAMIN D NOS], VITAMIN C [ASCORBIC ACID] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Soreness), PAIN (Body aches), PYREXIA (Fever of 100.7) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Ache, at an unspecified dose and frequency. At the time of the report, PAIN (Soreness), PAIN (Body aches), PYREXIA (Fever of 100.7) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.7 (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-240860 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received: Patient demographics, medical history, concomitant medication added; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I have not stopped itching. There is no visible rash but it is extremely intense. From my scalp to the bottoms of my feet, even inside my mouth. My hands are a little swollen. And when I scratch my face it becomes hard and red and swollen. It becomes more intense when I scratch but if I leave it alone it is still itchy. I have an extremely high pain tolerance and strong mental capacity. This is like nothing I have dealt with before. I cannot stop itching!
This spontaneous report was received from a nurse refers to an unspecified number of patients of unknown age and gender. Since July 2014 the patients were vaccinated with a dose of improperly stored GARDASIL (dose, route of administration and lot # were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Several days after the shot I had severe, crippling pain in both hands, wrists, shoulders, elbows, knees, upper arms that migrated from place to place. It lessened somewhat over the next couple of weeks but did not fully resolve before time for the second shot. After the second shot the symptoms came back even worse, to the point I had to seek medical care. The doctor prescribed Prednisone, which has helped some, but has not resolved symptoms. I have had increased swelling in feet and ankles, so a diuretic was prescribed. The pain has affected my ability to work, activities of daily living, ability to sleep at night because of pain. At times I need help to dress. I am in the process of being referred to a specialist. I also have fatigue and tire easily.
Information has been received from a mother concerning her 2 month old male child with no past medical history and no allergies who on 03/01/2002 was vaccinated with a dose of varicella virus vaccine live. This dose not comply with the recommended dosage schedule. There was no concomitant medication. On 03/02/2002 the pt became irritable and started "flipping out." It was reported that the child also had loss of appetite, abdominal pain, upper respiratory problems, disturbed sleep, nervousness, nausea, and chicken pox on his bottom. Then child was taken to a physician, who reportedly "felt as though the problems were not due to the shot." The mother went to another physician for a second opinion and was told that the child "may have bronchitis," and the physician gave the child azithromycin. On 03/03/2002 the pt developed a temperature of 103 deg F. The patient developed a temperature of 103 deg F. the pt reportedly had a "terrible temperature for several days." The mother did not want the pediatrician contacted. No further info is expected.
Pain at injection site laying two days Red rash near (but not at) the injection site two days after vaccination. Not painful, itchy, or warm. Just red.
Severe muscle and joint pain, cold chills, extreme fatigue, headache, weakness dizziness. Started one hour after injection. Has not yet resolved, 2 days after injection.
Developed a rash/hives on the right inside and outside elbow area within the first 24 hrs approximately. By Sunday evening, I also had a rash on the back of my right bicep area. The rash is raised bumps which appear to be similar to a blister. On Monday, the rash became more severe on my inner elbow area with severe itching. On Tuesday morning, I also had a small rash/blisters on my left inner forearm. On Tuesday, 4/27 I did go to my family doctor and was diagnosed with hives and being treated with Famotidine and Zyrtec.
Pt layed down on floor, started to shake & eyes rolled back in head approx 4 hrs p/vax; taken to ER & observed approx 5 hrs; suppositories were used for high fever;
two leaky heart valves; This is a spontaneous report received from a contactable consumer (patient, self-reported). A 67-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, solution for injection, lot number was unknow and expiry date was not reported), via an unspecified route of administration, in left arm, on 16Feb2021 at 01:15 PM, as a single dose for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Patient did not have any medical history and known allergies. Patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was tested for COVID-19, underwent COVID test type nasal swab, SARS-Cov2-RT PCR on 09Mar2021, result was negative. Patient's second dose of COVID vaccine was scheduled on 09Mar2021. It was reported that patient came to emergency room due to unrelated health problems with her heart. Patient had two leaky heart valves on an unknown date in 2021 and was hospitalized on an unknown date in 2021 for the event. She got out of the on 04Apr2021. Patient did not receive any treatment medications for the event. Seriousness of the event two leaky heart valves was reported as hospitalization. Outcome of the event was unknown.   Information on the lot and batch number has been requested.  Follow-up attempts have been completed and no further information is expected.
Left arm where shot was given is raised/swollen, red, irritated, itchy and rash looking
2 1/2min tonic clonic sz w/30min postictal state;temp 101 p/sz;following day had 2nd tonic clonic sz w/nl temp shortly a/t104 shortly after;
I lost all use of my left arm  within the period  of 4-5 hours accompanied by extreme pain in the shoulder and upper arm. I could not lift my arm from the shoulder and to attempt that movement  caused excruciating pain. The pain, which also began to be in the neck and elbow, kept me awake all night. I took ibuprofen and Tylenol with no relief.  On 10/26/2020 I was able to use my arm below the elbow,  which caused pain to the upper arm.  The following day I was able to lift the entire arm straight out with pain in the shoulder--but not acute. Today,  10/27 I am still having pain in the shoulder--not as acute as initially but still with some pain and am still unable to lift my arm straight up.
Client received FLUMIST on 10-22-15 from Dr, and received FLUMIST at school on 10-28-15.
After patient was given the Pfizer booster in the morning, patient was told to stay for 15 minutes for observation in the post vaccination area.  Per Rph, patient left after 5 minutes from the  area, and the accompanying mother screamed that her son  had collapsed.  Police Department and Ambulance arrived 5-7 minutes after being called immediately.  Firefighters say he had a hematoma around the  head area. RPH called the father and CT scans came out normal.  After everything  had happened, mother of the patient said he was nervous and had not eaten anything night prior. RPH confirmed that patient had mild symptoms with the first two covid shots.